PXR advises Vara on its €4.5 million funding round

Vara developed a breast cancer screening platform in 2018 to detect breast cancer earlier with the help of artificial intelligence. By combining proven, state-of-the-art technology with the experience and expertise of leading physicians, the company achieves measurable impact supported by clinical evidence.